Endocrine Topic Review. Sethanant Sethakarun, MD

Similar documents
CUSHING SYNDROME Dr. Muhammad Sarfraz

C h a p t e r 3 8 Cushing s Syndrome : Current Concepts in Diagnosis and Management

Cushing s Syndrome. Diagnosis. GuidelineCentral.com. Key Points. Diagnosis

Subclinical Cushing s Syndrome

Differential Diagnosis of Cushing s Syndrome

Cortisol levels. Naturally produced by the adrenal Cortisol

Cushing s syndrome and adrenal insufficiency

AVS and IPSS: The Basics and the Pearls William F. Young, Jr., MD, MSc Professor of Medicine Mayo Clinic College of Medicine Rochester, MN, USA

ULTIMATE BEAUTY OF BIOCHEMISTRY. Dr. Veena Bhaskar S Gowda Dept of Biochemistry 30 th Nov 2017

The endocrine system is made up of a complex group of glands that secrete hormones.

CUSHING S SYNDROME. Chapter 8. Case: A 43-year-old man with delusions

CHOLESTEROL IS THE PRECURSOR OF STERIOD HORMONES

MILD HYPERCORTISOLISM DUE TO ADRENAL ADENOMA: IS IT REALLY SUBCLINICAL?

Index. F Fatigue, 59 Food-dependent Cushing s syndrome, 286

AVS and IPSS: The Basics and the Pearls

27 F with new onset hypertension and weight gain. Rajesh Jain Endorama 10/01/2015

October 13, Surgical Nuances to Managing Cushing s Disease. Cortisol Regulation. Cushing s Syndrome Excess Cortisol. Sandeep Kunwar, M.D.

Approach to Adrenal Incidentaloma. Alice Y.Y. Cheng, MD, FRCP

PITUITARY: JUST THE BASICS PART 2 THE PATIENT

SECONDARY HYPERTENSION

The Investigation of suspected paediatric Cushing s Syndrome (hypercortisolaemia)

The Work-up and Treatment of Adrenal Nodules

CUSHING S SYNDROME THE FACTS YOU NEED TO KNOW

The diagnosis and differential diagnosis of endogenous Cushing s syndrome

The Pathological l Basis of Disease

Diseases of the Adrenal gland

Mineralocorticoids: aldosterone Angiotensin II/renin regulation by sympathetic tone; High potassium will stimulate and ACTH Increase in aldosterone

TREATMENT OF CUSHING S DISEASE

Cortisol (serum, plasma)

How to Recognize Adrenal Disease

ACTH-dependent Cushing s Syndrome Update AACE MI Chapter Annual Meeting September 22, Lynnette K. Nieman DEOB, NIDDK, NIH, DHHS

Clinical Study Clinical Characteristics of Endogenous Cushing s Syndrome at a Medical Center in Southern Taiwan

KNUH. Cushing s syndrome. Endocrinology & Metabolism KNUH

Pituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17

Indications for Surgical Removal of Adrenal Glands

Adrenal incidentaloma guideline for Northern Endocrine Network

Adrenal Disorders for the USMLE, Step One: Abnormalities of the Fasciculata: Hypercortisolism

Physiology. The Hypothalamic Pituitary Adrenal Axis. Elena A Christofides, MD, FACE

Endocrine MR. Jan 30, 2015 Michael LaFata, MD

2

Pituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group

Corticosteroids รศ. พญ. มาล ยา มโนรถ. Corticosteroids ภาคว ชาเภส ชว ทยา จ ดประสงค การศ กษา

ADRENAL INCIDENTALOMA. Jamii St. Julien

Neuroendocrine Disorders in Women

Subject Index. hypothalamic-pituitary-adrenal axis 158. Atherosclerosis, ghrelin role AVP, see Arginine vasopressin.

Pituitary Gland Disorders

CUSHING'S SYNDROME. Bharath University, Chrompet, Chennai, Tamil Nadu, India

Adrenal Tuberculosis in Cushing s Disease with Bilateral Macronodular Adrenocortical Hyperplasia

The Evaluation of the Incidental Adrenal Mass and Not-So-Incidental Adrenal Hormone Excess

Adrenal Ganglioneuroma Presenting With Adrenal Insufficiency After Unilateral Adrenalectomy

Diagnostic Testing in Cushing's Syndrome: Reassessment of 17-hydroxycorticosteroid and 17-ketosteroid Measurements

Evaluation of Thyroid Nodules

Adrenal Mass. Cynthia Kwong SUNY Downstate Medical Center Grand Rounds October 13, 2016

MedKorat Endocrine Day 2018 Approach to common adrenal disorder

Challenges in the diagnosis and management of Cushing s syndrome due to ectopic ACTH from bronchial carcinoid

Dimitrios Linos, M.D., Ph.D. Professor of Surgery National & Kapodistrian University of Athens

Professor Ian Holdaway. Endocrinologist Auckland District Health Board

Cushing Syndrome in Pediatrics

Sean Hamlett DO FACOI Endocrinology, Diabetes, and Metabolism Freeman Health System Joplin, MO

Therapeutic Objectives. Cushing s Disease Surgical Results. Cushing s Disease Surgical Results: Macroadenomas 10/24/2015

The analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS

Functional Pituitary Adenomas. Fawn M. Wolf, MD 2/2/2018

Incidental Adrenal Nodules Differential Diagnosis

False-positive inferior petrosal sinus sampling in the diagnosis of Cushing s disease

AN UNUSUAL PRESENTATION OF PEDIATRIC CUSHING DISEASE: DIABETIC KETOACIDOSIS

stone) Policy covered: in patients d): Korlym is enrolled in diabetes or glucose Cushing s syndrome adult patients with treated with metabolic caused

The endocrine system is complex and sometimes poorly understood.

Adrenal Incidentaloma Management

Cushings Syndrome. Cushings Syndrome

Checking the Right Box at the Right Age: the Art of Pediatric Endocrine Testing

The Investigation of Cushing Syndrome: Essentials in Optimizing Appropriate Diagnosis and Management

TEST NAME: DUTCH Adrenal

William F. Young, Jr., MD, MSc Professor of Medicine, Mayo Clinic, Rochester, MN USA

CUSHING S SYNDROME AND CUSHING S DISEASE

pharmacology sheet #9 Adrenal Steroids Mineral corticoids & Glucocorticoids

Treatment of Cushing s Syndrome: An Endocrine Society Clinical Practice Guideline

The Pathological l Basis of Disease

Endogenous Cushing s syndrome: The Philippine general hospital experience

57-year-old man with anxiety, diaphoresis, fatigue and bilateral adrenal nodules. Celeste Thomas November 1, 2012

Urinary Hormone Metabolites Adrenal

ACUTE SEVERE CUSHING SYNDROME: NOT ALWAYS ECTOPIC ACTH SYNDROME

Case Report Metyrapone for Long-Term Medical Management of Cushing s Syndrome

A short & obese - girl

Case Report Pediatric Cushing s Disease and Pituitary Incidentaloma: Is This a Real Challenge?

DIAGNOSIS OF CANINE HYPERADRENOCORTICISM: A CASE-BASED APPROACH Ellen N. Behrend, VMD, PhD, DACVIM

MANAGEMENT OF PATIENTS WITH CUSHING S DISEASE: A CANADIAN COST OF ILLNESS ANALYSIS

Adrenal gland Incidentaloma

Health Sciences Centre, Team A, Dr. L. Bohacek (Endocrine Surgery) Medical Expert

Endocrine Diseases. The Pathological Basis of Disease

Adrenal incidentaloma

COPYRIGHTED MATERIAL. Adrenal Imaging. 1.1 Introduction. Khaled M. Elsayes 1, Isaac R. Francis 1, Melvyn Korobkin 1 and Gerard M.

Adrenal and retropetionium

UW MEDICINE PATIENT EDUCATION. Cushing s Syndrome DRAFT. What is Cushing s syndrome? What is cortisol? What are the symptoms of Cushing s syndrome?

Il Carcinoma Surrenalico

Cushing s syndrome with no clinical stigmata a variant of glucocorticoid. resistance syndrome.

Year 2004 Paper two: Questions supplied by Megan 1

Case Based Urology Learning Program

A Comparison of Saliva & Wet Urine for Hormone Measurements

Rhythm Plus- Comprehensive Female Hormone Profile

Audit of Adrenal Function Tests. Kate Davies Senior Lecturer in Children s Nursing London South Bank University London, UK

Transcription:

Endocrine Topic Review Sethanant Sethakarun, MD

Definition Cushing's syndrome comprises a large group of signs and symptoms that reflect prolonged and in appropriately high exposure of tissue to glucocorticoids

Signs and Symptoms More specific: Reddish purple striae (>1 cm.wide) Facial plethora Proximal muscle weakness Easy bruising In children-weight gain with decreasing growth velocity

Signs and Symptoms High sensitivity Feature

Signs and symptoms

Pseudo-Cushing's Syndrome

Morbidity and Mortality Severe hypercortisolism: a median survival of 4.6 yr Most deaths caused by vascular (MI, CVA) or infectious complications. Treatment of patients with moderate to severe Cushing's syndrome clearly reduces mortality and morbidity.

Diagnosis

Severity of Cushingoid features depends on the potency of the preparation used, its dose, the route and duration of its administration. Current or recent use of these medication. Eg.skin creams, herbal medications, joint or nerve injections, synthetic progesterone derivative, etc. Exclude exogenous glucocorticoid exposure

Cushing's syndrome tends to progress, accumulation of new features increases the probability that the syndrome is present. In children, the sensitivity of combined reduced linear growth and increased weight is quite high. Patients with incidentally found adrenal nodule usually not present with overt clinical features of Cushing's syndrome, but biochemical hypercortisolism is present in a large fraction. Adrenal incidentaloma, usually not present with overt CS

False-positive results are reduced if case detection is limited to individuals with an increased pretest probability of having the disorder.

Diagnosis

Diagnosis

Initial testing

Initial testing ** **Not available in Thailand

Initial testing 4 recommended tests have acceptable diagnostic accuracy when the suggested cutoff points are used. If the initial testing results are normal, then the patient is very unlikely to have Cushing's syndrome. Initial testing!!

Estrogen increase the cortisol-binding globulin (CBG) in the circulation. Because serum assays measure total cortisol, false-positive rates for the overnight DST are seen in 50% of women taking the OCP. Estrogen-containing drugs should be withdrawn for 6 weeks before testing. Because the hypercortisolism of Cushing's syndrome can be variable, at least 2 measurements of urine or salivary cortisol are recommended.

Urine Free Cortisol (UFC) UFC reflects both urine metabolites and cortisol. Measures the cortisol that is not bound to CBG, which is filtered by the kidney unchanged. Values are significantly lower in patients with moderate to severe renal impairment. (GFR < 60 ml/min) UFC is not affected by conditions and medications that alter CBG!!

Urine Free Cortisol (UFC) Sample collection and instructions: Avoid the use of any glucocorticoid preparations. Because UFC levels in a patient with Cushing's syndrome are variable, at least two collections should be performed. Interpretation: UFC is 3 times higher than upper normal level -> positive

1-mg Overnight DST Supraphysiological dose of glucocorticoid results in suppression of ACTH and cortisol secretion. Endogenous Cushing's syndrome of any cause have a failure of this suppression.

1-mg Overnight DST Enzyme inducer drugs accelerate dexamethasone metabolism. Enzyme inhibitor drugs impair dexamethasone metabolism. OCP increase CBG and may falsely elevate cortisol.

1-mg Overnight DST Sample collection and instruction: 1 mg dexamethasone is given between 23.00-24.00, and cortisol is measured between 8.00-9.00 the following morning. Interpretation: Suppresible when serum cortisol less than 1.8 microgram/dl.

Low-dose DST Sample collection and instruction: Dexamethasone is given in doses of 0.5 mg for 48 hrs, beginning at 12.00 on day 1, at 6 hrs intervals. Serum cortisol is measured at 8.00 after the last dexamethasone dose. Interpretation: Suppresible when serum cortisol is less than 1.8 µg/dl. Improved specificity as compared with the 1-mg test

Some patients with Cushing's syndrome, usually those with mild or cyclic disease, may have discordant results.

Subsequent Evaluation

Subsequent Evaluation

Special Populations

Pregnancy: UFC excretion is normal in the first trimester, it increases up to 3-fold by term. Dexamethasone testing has an increased potential for false positive results in pregnancy.

Epilepsy: Anticonvulsants are enzyme inducer drugs. May cause false positive responses on testing.

Renal failure: Excreted urine cortisol values decrease below creatinine clearance of 60 ml/min, and quite low, below 20 ml/min.

Cyclic Cusing's syndrome: Measurement of UFC or salivary cortisol may best demonstrate cyclicity. If initial tests are normal but high suspicion, follow-up is recommended with repeat testing.

Adrenal incidentaloma: UFC appears to be less sensitive than the 1-mg DST or late night cortisol. A suppressed ACTH or dehydroepiandrosterone sulfate concentration supports the diagnosis of Cushing's syndrome in patients with adrenal mass.

Determining the Cause Determining the cause Plasma ACTH High-dose dexamethasone suppression test (HDDST)

Determining the Cause ACTH level

Plasma ACTH Collect plasma ACTH at 8.00-9.00 and the sample should be kept cool all the time. Using EDTA tube

Plasma ACTH Interpretation: ACTH < 10 pg/ml ->ACTH-independent Cushing's syndrome. ACTH > 20 pg/ml ->ACTH-dependent Cushing's syndrome. ACTH 10-20 pg/ml-> repeating ACTH levels.

High-dose DST For ACTH dependent Cushing's syndrome. Measure baseline morning cortisol. 2 methods: 1. HDDST-dexamethasone 8 mg at 23.00-24.00 and measure serum cortisol at 8.00-9.00. 2. Standard HDDST-Dexamethasone 2 mg every 6 hrs for 48 hrs and measure serum cortisol 2-6 hrs after last dose of dexamethasone.

High-dose DST Interpretation: Suppressible if serum cortisol decrease from baseline 50% or more. If not suppressible: 1. Ectopic ACTH 2. Pituitary macroadenoma

Pituitary MRI Should be done in all patients with ACTHdependent Cushing's syndrome.

Bilateral Inferior Petrosal Sinus Sampling (BIPSS) For ACTH-dependent Cushing's syndrome with normal finding in pituitary MRI. Require experienced intervention radiologist. Measure petrosal:peripheral ACTH ratio, positive if ratio = 2 or >3 after CRH

Ectopic ACTH CT chest and Abdomen Eg. SCLC, carcinoid tumor, islet cell tumors, medullary thyroid cancer, pheochromocytoma "รถ" "แพน" "ค นเล ก" "หมอเม ด" "ให ฟร "

ACTH-independent CS CT or MRI adrenal glands -> Adrenal tumor.

Treatment Treat complication from hypercortisolism: HT, DM, osteoporosis, gonadal axis. Treat the cause: ACTH-independent: benign adrenal adenoma, adrenocortical carcinoma Pituitary adenoma Ectopic ACTH

Treatment Adrenal Adenoma: unilateral adrenalectomy Adrenocortical carcinoma: remove primary tumor followed with adrenolytic agent Pituitary micro/macroadenoma: transphenoidal pituitary surgery Ectopic ACTH: depend on the type of tumor

Treatment Adjuvant medical therapy: Inhibit corticosteroid synthesis: ketoconazole, metyrapone Block corticosteroid effect: mifepristone Cytotoxic to adrenal cortical cells: mitotane

Reference The Diagnosisn of Cushing's syndrome, The Endocrine Society's clinical guideline.(j Clin Endocrinol Metab93:1526-1540, 2008) Evidence-based Clinical Practice Guidelines in Endocrinology, สาขาว ชาต อมไร ท อและเมตาบอล สม ภาคว ชาอาย รศาสตร คณะแพทยศาสตร จ ฬาลงกรณ มหาว ทยาล ย MKSAP 15, Endocrinology and Metabolism, American College of Physicians. Pocket Medicine, 4th Edition